- Home
- Life Sciences
- Biotechnology
- Biotechnology Analysis & Statistics in the United States, January 2010 (p20)
Talk to Robyn
00 1 718 213 49 04
Search inside this page
Publication dates
Publishers
- Global Data (269)
- Global Markets Direct (131)
- Currentpartnering (3)
- France Innovation Scientifique et Transfert (2)
- Ibisworld (3)
-
- MarketLine (61)
- RNCOS (4)
- IData Research, Inc. (16)
- CHI Insight Pharma Reports (13)
- Euromonitor International (2)
- Frost & Sullivan (26)
- La Merie Publishing (6)
- Datamonitor (39)
- Global Industry Analyst (20)
- SCRIP Insights (18)
- ICD Research (17)
- Freedonia (13)
- Business Review (10)
- Espicom Business Intelligence (10)
- Life Science Analytics (LSA) (10)
- GBI Research (9)
- Kalorama Information (7)
- Visiongain (6)
- BioPlan Associates, Inc. (4)
- Industry Experts (4)
- TriMark Publications (4)
- BCC Research (3)
- BioPharm Reports (3)
- Canadean Ltd (3)
- Aruvian's R'search (2)
- Infiniti Research Limited (2)
- Koncept Analytics (2)
- MarketsandMarkets (2)
- Packaged Facts (2)
- Pharmavision (2)
- Plunkett Research (2)
- ABMRG (1)
- BioInformatics (1)
- Daedal Research (1)
- Firstword Pharma (1)
- International Market Analysis Research and Consult (1)
- Ken Research Private (1)
- Urch Publishing (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
All regions
- All
- North America
- United States
data types
Free Market Research Guides to Download
Biotechnology Analysis & Statistics in the United States, January 2010 (p20)
You might be interested in: biotech, biomedical, biomaterials, more »
» Purchase Premium Reports
571-600 of about 600 reports
Company Financials: ADVENTRX Pharmaceuticals, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Healthcare
- Countries : United States
Company Financials: Cadence Pharmaceuticals
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Healthcare
- Countries : United States
Company Financials: Isis Pharmaceuticals, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biological Therapy, Healthcare
- Countries : United States
Company Financials: Keryx Biopharmaceuticals, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Healthcare
- Countries : United States
Company Financials: Illumina, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Genomics, Healthcare
- Countries : United States
Company Financials: Affymax, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Healthcare
- Countries : United States
Company Financials: OSI Pharmaceuticals
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Healthcare
- Countries : United States
Company Financials: Sangamo Biosciences, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biotechnology, Healthcare
- Countries : United States
Company Financials: Seattle Genetics, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Genomics, Healthcare
- Countries : United States
Company Financials: Novavax, Inc.
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Healthcare
- Countries : United States
Company Financials: Celgene Corporation
- $ 75
- Company report
- January 2010
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Healthcare
- Countries : United States
Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities
- $ 2 368
- Industry report
- January 2010
- by BioPharm Reports
Cancer Stem Cell (CSC) research has accelerated in the last two years and considerable efforts are now being made to identify drug molecules that selectively target and destroy them. Today, 50 developmental ...
- Industries : Biological Therapy, Drug Discovery and Development, Therapy
- Countries : United States
U.S. Epigenetics Markets
- $ 6 000
- Industry report
- December 2009
- by Frost & Sullivan
This research service analyzes the market for epigenetics products within the United States. The market was divided into the bisulfite conversion kits and chromatin immunoprecipitation segments. Each segment ...
- Industries : Genomics, Biotechnology
- Countries : United States
Applied Biosystems, Inc. SWOT
- $ 175
- Company report
- December 2009
- by MarketLine
examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Applied Biosystems is engaged in the development ...
- Industries : Genomics, Healthcare, It Services
- Countries : United States
Strategic Analysis of the Home and Fabric Care Specialty Ingredients Markets in North America
- $ 6 000
- Industry report
- December 2009
- by Frost & Sullivan
This market analyses the specialty ingredients which are used in the formulation of the home care and fabric care products like hard surface cleaners, detergents, dish washing powders, car cleaners and ...
- Industries : Pesticide, Biotechnology, Cleaning Compound
- Countries : North America, United States, World
Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics
- $ 3 835
- Industry report
- November 2009
- by SCRIP Insights
The study of epigenetics - changes in gene expression that occur without a change in a cell's DNA code - is becoming increasingly important as scientists explore how internal and external factors trigge ...
- Industries : Genomics, Therapy, Diagnostics
- Countries : United States, Australia, Germany, Denmark
Pharmaceutical in United States: Millipore Corporation - SWOT analysis
- $ 175
- Company report
- November 2009
- by MarketLine
Millipore Corporation - SWOT Analysis industry player profile is the essential source for top-level industry player data and information. Millipore Corporation - SWOT Analysis examines the firm ?s key ...
- Industries : Therapy, Biotechnology, Pharmaceutical
- Countries : United States
Biosimilars: Beyond the first product wave
- $ 2 268
- Industry report
- October 2009
- by Espicom Business Intelligence
With the prospect of high-profile, high-value biosimilar products on the horizon, the sector is poised to realise its full potential - but only if the US can establish a regulatory pathway. The future ...
- Industries : Biopharmaceutical, Healthcare, Pharmaceutical, Biotechnology
- Countries : United States, World, Europe
Danisco
- $ 75
- Company report
- October 2009
- by Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information ...
- Industries : Biopharmaceutical, Food Ingredient, Consumer Trends
- Countries : Denmark, United States, Europe
The Market Outlook for Research Products in FY2010
- $ 3 200
- Industry report
- October 2009
- by BioInformatics
Gearing up for a more prosperous FY2010, The Market Outlook for Research Products in FY2010 compares and contrasts FY2009 (actual) and FY2010 (projected) budgets in total and by product category with a ...
- Industries : Drug Discovery and Development, Research and Development, Biotechnology, Pharmaceutical
- Countries : United States
Biomimetics--Trends Inspired by Nature (Technical Insights)
- $ 6 500
- Industry report
- September 2009
- by Frost & Sullivan
This research service provides an insight on key research initiatives happening around the globe in the biomimetic space, in addition to providing a roadmap that lists potential applications of biomimetic ...
- Industries : Biotechnology
- Countries : United States
U.S. Knee Implants Market
- $ 6 000
- Industry report
- September 2009
- by Frost & Sullivan
This research service studies the orthopedic knee replacement market in the United States. The market is segmented as primary implants and revision implants. It covers the market from the aspects of the ...
- Industries : Orthopedic, Biomaterial
- Countries : United States
Cell and Tissue Analysis Products: The Global Market
- $ 5 450
- Industry report
- September 2009
- by BCC Research
STUDY GOALS AND OBJECTIVES This report, Cell and Tissue Analysis Products: The Global Market, provides a detailed analysis of the products and technologies that define the market space and summarizes the ...
- Industries : In Vitro Diagnostic, Biomaterial
- Countries : World, United States
Bioheart, Inc. SWOT Analysis and Financial Profile
- $ 125
- Company report
- August 2009
- by Global Markets Direct
(Bioheart) is a biotechnology firm , engaged in the development and industry ing of autologous cell therapies for the cardiovascular industry s. It develops autologous cell therapies which is used fo ...
- Industries : Biological Therapy, Medical Equipment and Supply
- Countries : World, United States
Biophan Technologies, Inc. SWOT Analysis and Financial Profile
- $ 125
- Company report
- August 2009
- by Global Markets Direct
The industry player develops innovative technologies with the goal of making all biomedical devices capable of safely and successfully working with magnetic resonance imaging (MRI). The industry playe ...
- Industries : Biomaterial, Medical Equipment and Supply
- Countries : United States
Cellestis Limited SWOT Analysis and Financial Profile
- $ 125
- Company report
- August 2009
- by Global Markets Direct
The industry player products are medical diagnosis, scientific research and line in tube blood incubation step. Cellestis develops and industry s QuantiFERON technology products for medical diagnosis ...
- Industries : Biological Therapy, Medical Equipment and Supply
- Countries : United States, World, Australia, Japan
Bioneer Corporation SWOT Analysis and Financial Profile
- $ 125
- Company report
- August 2009
- by Global Markets Direct
The industry player provides solutions to the global community of researchers, academia, biotech and pharmaceutical firms . Bioneer invested in the integration of recombinant DNA technology, fermentation, ...
- Industries : Biotechnology, Medical Equipment and Supply
- Countries : World, United States
Affymetrix, Inc. SWOT Analysis and Financial Profile
- $ 125
- Company report
- August 2009
- by Global Markets Direct
(Affymetrix) is engaged in the business of development, production, sales and servicing of consumables and equipment systems for genetic analysis in the life sciences and clinical healthcare industry ...
- Industries : Genomics, Medical Equipment and Supply
- Countries : United States, Japan, World
Artimplant AB SWOT Analysis and Financial Profile
- $ 125
- Company report
- August 2009
- by Global Markets Direct
The industry player is engaged in the development, manufacture and industry ing of degradable implants that restores the health of patients and helps the body to heal. The industry player has its operations ...
- Industries : Biomaterial, General Medicine and Specialty Medicine, Medical Equipment and Supply
- Countries : Sweden, United States, World
Amplifon S.p.A. SWOT Analysis and Financial Profile
- $ 125
- Company report
- August 2009
- by Global Markets Direct
p.A. (Amplifon) is a multinational industry player based in Italy. The industry player is engaged in the distribution and application of hearing aids and correlated services. Amplifon develops, manufactures, ...
- Industries : Biomaterial, Medical Equipment and Supply
- Countries : Italy, World, Switzerland, Netherlands, Europe, United States, Canada, Spain, Portugal, Hungary, France, Egypt
» Download Public Reports
About 2 600 reports
Company Report: Biological Therapy in The United States for Year 2013
- Company report
- April 2013
- 17 pages
... From funding. The doc/nist will review research using human embryonic stem cell lines that it supports and conducts in accordance with the common rule and nist implementing procedures, as appropriate ...
U.s. Antibody Industry Brief
April 2013U.s. Biotechnology Business Analysis
April 2013U.s. Gmo Sector Brief
May 2013» Read our Company Profiles
22 CompaniesJohnson and Johnson
United StatesGlaxoSmithKline P.L.C.
United StatesSanofi-Aventis Senegal
SenegalBiogen Idec
United StatesAbbott Laboratories
United StatesReportlinker.com © Copyright 2013. All rights reserved.
